124 related articles for article (PubMed ID: 36963882)
1. Systematic review and meta-analysis: Associations of vitamin D with pulmonary function in children and young people with cystic fibrosis.
Iniesta RR; Cook S; Oversby G; Koufaki P; Van der Linden ML; Vlachopoulos D; Williams CA; Urquhart DS
Clin Nutr ESPEN; 2023 Apr; 54():349-373. PubMed ID: 36963882
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. The impact of plasma 25-hydroxyvitamin D on pulmonary function and exercise physiology in cystic fibrosis: A multicentre retrospective study.
Revuelta Iniesta R; Causer AJ; Arregui-Fresneda I; Connett G; Allenby MI; Daniels T; Carroll MP; Urquhart DS; Saynor ZL
J Hum Nutr Diet; 2022 Apr; 35(2):363-375. PubMed ID: 33908093
[TBL] [Abstract][Full Text] [Related]
4. Association of vitamin D status with lung function measurements in children and adolescents with cystic fibrosis.
Loukou I; Moustaki M; Sardeli O; Plyta M; Douros K
Pediatr Pulmonol; 2020 Jun; 55(6):1375-1380. PubMed ID: 31338968
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Smith S; Lykkesfeldt J
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007020. PubMed ID: 31580490
[TBL] [Abstract][Full Text] [Related]
6. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D status correlates with the markers of cystic fibrosis-related pulmonary disease.
Wani WA; Nazir M; Bhat JI; Malik EU; Ahmad QI; Charoo BA; Ali SW
Pediatr Neonatol; 2019 Apr; 60(2):210-215. PubMed ID: 30093293
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.
Wolter DJ; Onchiri FM; Emerson J; Precit MR; Lee M; McNamara S; Nay L; Blackledge M; Uluer A; Orenstein DM; Mann M; Hoover W; Gibson RL; Burns JL; Hoffman LR;
Lancet Respir Med; 2019 Dec; 7(12):1027-1038. PubMed ID: 31727592
[TBL] [Abstract][Full Text] [Related]
10. Vitamin A and beta (β)-carotene supplementation for cystic fibrosis.
de Vries JJ; Chang AB; Bonifant CM; Shevill E; Marchant JM
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006751. PubMed ID: 30091146
[TBL] [Abstract][Full Text] [Related]
11. Serum 25-hydroxyvitamin D response to vitamin D supplementation in infants: a systematic review and meta-analysis of clinical intervention trials.
Zittermann A; Pilz S; Berthold HK
Eur J Nutr; 2020 Feb; 59(1):359-369. PubMed ID: 30721411
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D deficiency is associated with pulmonary exacerbations in children with cystic fibrosis.
McCauley LA; Thomas W; Laguna TA; Regelmann WE; Moran A; Polgreen LE
Ann Am Thorac Soc; 2014 Feb; 11(2):198-204. PubMed ID: 24083951
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Lykkesfeldt J
Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D intake, serum 25-hydroxy vitamin D and pulmonary function in paediatric patients with cystic fibrosis: a longitudinal approach.
Timmers NKLM; Stellato RK; van der Ent CK; Houwen RHJ; Woestenenk JW
Br J Nutr; 2019 Jan; 121(2):195-201. PubMed ID: 30442206
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation for cystic fibrosis.
Ferguson JH; Chang AB
Cochrane Database Syst Rev; 2014 May; (5):CD007298. PubMed ID: 24823922
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma.
Li F; Peng M; Jiang L; Sun Q; Zhang K; Lian F; Litonjua AA; Gao J; Gao X
Respiration; 2011; 81(6):469-75. PubMed ID: 21124013
[TBL] [Abstract][Full Text] [Related]
17. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
18. Inhaled mannitol for cystic fibrosis.
Nevitt SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
[TBL] [Abstract][Full Text] [Related]
19. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
20. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
McIlwaine M; Button B; Nevitt SJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31774149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
